Abacus Life (NASDAQ:ABL – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03, Zacks reports. The firm had revenue of $33.21 million during the quarter, compared to analyst estimates of $28.76 million. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%.
Abacus Life Trading Down 0.8 %
ABL opened at $7.15 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. The stock’s fifty day moving average is $7.61 and its two-hundred day moving average is $8.31. The company has a market capitalization of $691.01 million, a P/E ratio of -39.72 and a beta of 0.14. Abacus Life has a 52 week low of $6.75 and a 52 week high of $12.50.
Analysts Set New Price Targets
Separately, B. Riley decreased their target price on Abacus Life from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Abacus Life presently has an average rating of “Buy” and a consensus price target of $14.30.
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Read More
- Five stocks we like better than Abacus Life
- What is a support level?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is a Stock Market Index and How Do You Use Them?
- Top 3 Beverage Stocks Pouring Out Profits
- Compound Interest and Why It Matters When Investing
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.